T ogether, the 2 papers in this In Review series 1,2 on the effectiveness of interventions for alcohol use disorders (AUDs) represent a comprehensive synthesis of the relevant literature and will serve as the go-to resource for some years for Canadian and international researchers, as well as for government and community decision-makers involved in funding, developing policy, and administering and delivering treatment and support services. As comprehensive as the 2 papers are, Dr Bernard Le Foll and colleagues (see Lev-Ran S et al 1 ) and Dr Garth W Martin and Dr Jürgen Rehm 2 acknowledge several limitations that the reader should keep in mind, most notably the limited attention given to special populations, such as youth, women, older adults, and diverse communities. For some of these subpopulations (for example, First Nations or subpopulations based on gender diversity) the research findings are not substantive enough to draw firm conclusions regarding the most effective interventions. In other instances, such as the treatment of adolescents and youth, it was a matter of keeping the reviews in reasonable scope and managing space limitations. Certainly the literature on the treatment of adolescents and youth is very well developed 3 and strong enough to warrant the same general conclusion as presented in the 2 review papers 1,2 ; namely, that substance use treatment works and returns the economic investment through reductions in health care use and criminal justice and other costs at the societal level. Today's most relevant questions for intervention research focus on what works best from a comparative point of view, under what modifying or mediating conditions, and with what degree of cost-effectiveness.
Aside from issues related to subpopulations, there are 5 broad contextual factors that the reader must consider when reading and distilling key learnings from the 2 reviews. 1, 2 First, the charge given to the authors was to synthesize the treatment literature related to alcohol abuse and dependence and not other psychoactive drugs of abuse. While there is some legitimacy to the development of substance-specific interventions (for example, specific pharmacologic interventions for AUDs), the trend during the last several years in most specialized treatment settings has been toward a diverse, multiple drug-using client population. The treatment population has diversified to the extent that programs are often challenged to identify the primary drug of abuse. In Ontario, for example, the most recent data from the provincial Drug and Alcohol Treatment Information System (commonly referred to as DATIS) yield the following breakdown-alcohol only 33%, drug only 31%, and combined alcohol and drug 36% (excluding family members who are also seen as system clients in their own right). These data have held steady for the past several years. By implication, interventions need to be as adaptable as possible across substances, while recognizing the need for some specialization for pharmacological intervention. It also means that treatment research samples, even if they are cleaned to reduce contamination by substances other than the drug of primary interest for the research question, yield study results that may or may not apply in real-life, mixed drug-using treatment populations. Thus both efficacy trials and field effectiveness studies are needed to advance the substance use field.
The second important factor to keep in mind in applying the results of these 2 important reviews is that, while they focus on the interventions, someone has to engage the client and deliver them with competence, respect, and empathy. The paper by Dr Martin and Dr Rehm 2 notes the importance of "therapist effects" p 352 and these effects are by no means trivial. In the adult and youth literature alike it is surprising how few clinically significant differences emerge in studies comparing the effectiveness of different interventions. The psychotherapy literature suggests that therapeutic alliance may account for as much as 30% of the variance in treatment outcome. The same general finding may well hold for substance abuse treatment.
The third point is that the interventions covered in the 2 reviews need to be planned, financed, delivered, and evaluated for effectiveness in a well-functioning system of care and support. Gone are the days when clinicians and programs are able to work in isolation. Rush and Ogborne 4 and Ogborne et al 5 traced the development of the specialized sector of alcohol and drug treatment services in Canada, noting the broader perspective of the treatment system that began to emerge in the 1990s following a seminal report of the American Academy of Medicine. 6 This broader perspective calls for the involvement of multiple sectors and professionals more actively screening and engaging individuals and their families in assessment and (or) treatment where they present for various forms of assistance. This includes, for example, primary care, emergency and other hospital services, mental health, justice, education, and social assistance. Although this broader systems perspective has largely been given lip service by system planners for the past 2 decades, it has been embraced in Canada through the report of the National Treatment Strategy Working Group 7 and its plan for a systems approach to substance use treatment. To help operationalize this systems perspective, chronic care models and tiered service delivery frameworks have been advocated. 8 Further, the many concrete policy, structural, and programmatic efforts to better integrate mental health and addiction services in Canada and elsewhere 9,10 should be seen in the context of broadening the base of treatment, as should more recent work on collaborative care models for substance use, mental health, and primary care. 11 These efforts are critical to expanding access to substance use treatment by clearly recognizing that only a small percentage of people with substance use disorders (SUDs) seek help from the specialized sector of substance use services. To effect a population-level impact, substance use treatment must become everyone's business. 12 Making it everyone's business also calls for improved educational curricula and continuing education programs for a wide range of health and social service professionals, including physicians. System planning models and methods are also needed that articulate the importance of such things as common screening and assessment tools, agreed-on placement protocols, transition and linkage supports, and infrastructure, such as e-health and electronic records, to efficiently share information across providers and monitor health outcomes. Engaging multiple sectors and disciplines in system planning is challenged by the multiple perspectives on SUDs and personal and professional biases toward particular approaches and desired outcomes. Local experience in planning integrated systems of substance use treatment and support suggest that progress can be made toward a seamless client experience only after all concerned service providers and planners get on the same page.
Fourth, at present there are no routine systems in place to monitor whether the interventions, and the systems of care in which they are delivered, are yielding good outcomes in practice settings. This is not unique to substance use services as the health sector generally, including mental health, has only recently taken outcome assessment seriously. By that we mean going beyond the counting of cases, the description of case mix, and documentation of service events to truly embrace the routine measurement of health outcomes and (or) indicators of access and continuity of care that predict health outcomes. 13 Rush et al 14 provide an overview of comprehensive performance measurement systems for substance use services, including outcome monitoring. The 2 major conceptual developments related to outcome monitoring are the adoption of brief, standardized withintreatment outcome assessment to measure client progress on an ongoing basis rather than one-off posttreatment outcome determination 15 ; and Recovery Monitoring Checkups (RMCs), which assess posttreatment progress on a routine basis but with a protocol in place to return the individual to treatment if outcomes are at a critically low cut-off. 16, 17 Importantly, in both the within-treatment and the RMC models, outcome monitoring essentially becomes an integrated component of the treatment and support process itself and not an ancillary, costly add-on.
Last, there is a significant gap between what interventions we know work and what is routinely delivered in practice settings. This implementation gap is not news, as the same challenge plagues most, if not all, of health care, including mental health generally. 18 The substance use field has been among the leaders in health care in the development and deployment of strategies to support uptake evidence-informed practices on a large scale across treatment systems. That said, Canada is now just catching up to other jurisdictions, such as the United States and Australia, in closing the implementation gap. Knowledge exchange networks are being developed nationally, and in many provinces, to better link research and decisionmakers at multiple levels, including front-line clinicians. Some provinces and territories are using funding from the 2008-13 Drug Treatment Funding Program to support such networks and provide specific training and infrastructure for knowledge exchange. Methods are also being adopted and adapted from the rapidly growing literature on implementation science and the knowledge base is growing on what is not effective (for example, guideline dissemination and training alone) and what is effective (for example, coaching and fidelity assessment) when it comes to changing practice. 19 In sum, the 2 excellent reviews in this In Review 1,2 series on interventions for treatment of AUDs must be complimented with an awareness that these interventions need to be delivered by competent, emphatic people; planned and implemented in the context of an integrated system of services and supports beyond the specialist sector; evaluated for effectiveness, with clinically useful outcome monitoring models and measures; and, implemented on a large scale, with a reasonable degree of fidelity. With these features in place, substance use treatment and support is likely to have a population-level impact and thereby reduce the heavy societal burden incurred by SUDs.
